The relationship between thyroid transcription factor-1 positivity and epidermal growth factor receptor mutation in lung adenocarcinoma and its prognostic significance
dc.contributor.author | Katgi, Nuran | |
dc.contributor.author | Cimen, Pinar | |
dc.contributor.author | Akyol, Murat | |
dc.contributor.author | Aguloglu, Nursin | |
dc.date.accessioned | 2024-03-09T18:48:43Z | |
dc.date.available | 2024-03-09T18:48:43Z | |
dc.date.issued | 2023 | |
dc.department | İzmir Bakırçay Üniversitesi | en_US |
dc.description.abstract | BACKGROUND AND AIM: Thyroid transcription factor-1 (TTF-1) is a good prognostic factor and is also thought to be associated with driver mutations in lung cancer. This study aimed to evaluate the relationship between TTF-1 expression and prognosis and driver mutations in lung adenocarcinomas.METHODS: We analyzed the data of 307 patients who were diagnosed with lung adenocarci-noma and underwent TTF-1 testing in two centers between January 2018 and January 2021. RESULTS: Of the 307 patients included in the study, 231 were TTF-1 positive, 23 were weakly positive, and 53 were negative. There was no statistically significant relationship between TTF-1 positivity and progression-free survival (PFS) (p=0.492). However, overall survival (OS) was significantly longer in TTF-1 positive patients (p=0.005). Both PFS and OS were sig-nificantly longer in TTF-1 positive patients with multiple metastates (p=0.001, p=0.013). Of the 199 patients who underwent epidermal growth factor receptor (EGFR) mutation analysis, EGFR positivity was detected in 62 of them, and 58 patients were found to be in the TTF-1 positive group (p=0.022). CONCLUSIONS: Thyroid transcription factor-1 positivity in lung adenocarcinomas is a good prognostic factor that often accompanies EGFR positivity. | en_US |
dc.identifier.doi | 10.14744/ejp.2022.1204 | |
dc.identifier.endpage | 140 | en_US |
dc.identifier.issn | 2148-3620 | |
dc.identifier.issn | 2148-5402 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 133 | en_US |
dc.identifier.uri | https://doi.org/10.14744/ejp.2022.1204 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14034/1428 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:001050294700008 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Kare Publ | en_US |
dc.relation.ispartof | Eurasian Journal of Pulmonology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Epidermal Growth Factor Receptor (Egfr); Lung Adenocarcinoma; Prognosis; Thyroid Transcription Factor-1 (Ttf-1) | en_US |
dc.title | The relationship between thyroid transcription factor-1 positivity and epidermal growth factor receptor mutation in lung adenocarcinoma and its prognostic significance | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1